Anti-Human ST14 Antibody (A11) from ProteoGenix; catalogue ARO-A22766; research use only.
Know who made it. See the evidence. Buy through one marketplace.
The Anti-Human ST14 Antibody (A11) is a highly specific and potent antibody designed for the detection of ST14 protein in human cells. ST14, also known as matriptase, is a type II transmembrane serine protease that plays a crucial role in various biological processes such as cell proliferation, differentiation, and tissue homeostasis.
This antibody is ideal for use in various applications, including Western blotting, immunohistochemistry, and flow cytometry. It has been extensively tested and validated for its specificity, sensitivity, and reproducibility, making it a reliable tool for researchers in the biotech industry.
The Anti-Human ST14 Antibody (A11) is a valuable tool for studying ST14 protein expression and function in different cell types and tissues. It has been shown to specifically recognize the active form of ST14, making it an essential tool for understanding the role of this protease in various physiological and pathological conditions.
In addition, this antibody has been successfully used in experiments to investigate the involvement of ST14 in cancer progression, wound healing, and inflammation. Its high specificity and sensitivity make it a valuable tool for identifying potential therapeutic targets and developing novel treatments for various diseases.
With its excellent performance in multiple experimental techniques and its ability to specifically detect active ST14, the Anti-Human ST14 Antibody (A11) is an essential tool for researchers studying this important protease. Its high-quality and reliable results make it a valuable addition to any biotech laboratory.
In summary, the Anti-Human ST14 Antibody (A11) is a highly specific and potent antibody that is ideal for studying the biological function of ST14 in various research areas. Its versatility, reliability, and specificity make it an essential tool for any biotech researcher looking to advance their understanding of ST14 and its role in human health and disease. Order now and take your ST14 research to the next level.
ProteoGenix catalogue number ARO-A22766. For research use only.
Target: Suppressor of tumorigenicity 14 protein, EC:3.4.21.109, Matriptase, Membrane-type serine protease 1, MT-SP1, Prostamin, Serine protease 14, Serine protease TADG-15, Tumor-associated differentially-expressed gene 15 protein, ST14, PRSS14, SNC19, TADG15; Clonality: Monoclonal Antibody; Reactivity: Human; Applications: ELISA, IF/ICC.
Available configurations: 50ug, 100ug, 1mg.
Fully tested in-house by ABMIUM, or supported by an advanced validation report from a partner reviewed by ABMIUM. Highest confidence. Non-conformities fully supported under the ABMIUM Product Promise.
Quality verified. Independent collaborator or expected-performance data available. Product meets ABMIUM quality standards.
Expected to work based on structural and biochemical data. Not yet directly tested by ABMIUM or a collaborator. No non-conformity support for this combination.
Not recommended for this application or species/sample combination. This may indicate either evidence of unsuitability or that the combination has not been tested and therefore cannot currently be recommended.
Evidence status by application and model.
| Species | WB | IHC-P | IHC-Fr | IF/ICC | Flow Cyt | IP | ChIP | ELISA |
|---|---|---|---|---|---|---|---|---|
| Human |
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
